NVP-BGT226 (BGT226）
产品编号: DC3133
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
NVP-BGT226 is a novel dual PI3K/mTOR inhibitor with IC50 of 1 nM.
| Cas No.: |
1245537-68-1 |
| 名称: |
8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleic acid |
| 别名: |
BGT-226,NVP BGT226 (BGT226） |
| SMILES: |
COC1=CC=C(C=N1)C2=CC=C(C3=C2)N=CC(N4C)=C3N(C4=O)C5=CC=C(C(C(F)(F)F)=C5)N6CCNCC6.OC(/C=CC(O)=O)=O |
| 分子式: |
C28H25F3N6O2.C4H4O4 |
| 分子量: |
650.6 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Description of BGT226: BGT226 is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger th |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
